Voyager Therapeutics, Inc.
VYGR· Nasdaq
VYGRVoyager Therapeutics, Inc.
Filed Aug 11, 2016 · 10-Q · 42 days after period end · 0001558370-16-007918
| Metric | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|
| Revenue | $3.72M | $4.88M | — |
| Net Income | -$9.34M | -$3.90M | — |
| EPS Diluted | $0.37 | $5.80 | $8.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Voyager Therapeutics, Inc. · CIK 1640266 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 11, 2016 · 42 d after period end
